Nithya Santhana Krishnan, United Kingdom
The (Unspoken) Risks of Over-Immunosuppression

Stefan Schneeberger, Austria
Regulatory Pathways and Barriers to Innovation: Lessons from the EMA

Ulf Meier-Kriesche, United States
Industry Partners: Friends or Foes?

Dirk Kuypers, Belgium
Can Technology and Therapeutic Monitoring Strategies Improve the Gap?

Michael Collins, Australia
Structuring Trials of Novel Agents: Risks and Opportunities